• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

JPM2024: Big Tech Poised to Disrupt Biopharma with AI-Based Drug Discovery

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 10, 2024 at 10:02: AM
via 2024 will continue to see Big Tech companies enter the artificial intelligence-based drug discovery space, potentially disrupting the biopharma industry. That was the consensus of panelists at a Tuesday session on AI and machine learning held by the Biotech Showcase, co-located with the 42nd J.P. Morgan Healthcare Conference.

article source
 




Top Bottom
Back
Quote